HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrey V Lisitsa Selected Research
Andrey V Lisitsa Research Topics
Disease
3
Neoplasms (Cancer)
01/2020 - 01/2014
1
Nervous System Diseases (Neurological Disorders)
01/2023
1
Adenocarcinoma of Lung
01/2023
1
Obesity
01/2021
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021
1
Colorectal Neoplasms (Colorectal Cancer)
01/2020
1
Rheumatoid Arthritis
02/2018
1
Ankylosing Spondylitis
02/2018
1
Glioblastoma (Glioblastoma Multiforme)
01/2017
1
Hepatocellular Carcinoma (Hepatoma)
01/2014
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
01/2020 - 01/2014
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2017
2
Proteome
IBA
12/2014 - 01/2014
2
Peptides (Polypeptides)
IBA
12/2014 - 01/2014
1
Complement Factor H (Factor H)
IBA
01/2023
1
Gelsolin
IBA
01/2023
1
Ceruloplasmin (Ferroxidase)
IBA
01/2023
1
Protein Isoforms (Isoforms)
IBA
01/2023
1
alpha-2-HS-Glycoprotein
IBA
01/2020
1
Glycoproteins (Glycoprotein)
IBA
01/2020
1
Haptoglobins
IBA
01/2020
1
Kininogens (Kininogen)
IBA
01/2020
1
Leucine (L-Leucine)
FDA Link
01/2020
1
Orosomucoid (Seromucoid)
IBA
01/2020
1
Vitamin D-Binding Protein
IBA
01/2020
1
Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)
IBA
01/2020
1
inter-alpha-inhibitor
IBA
01/2020
1
Suspensions
IBA
02/2018
1
Betamethasone (Celestone)
FDA Link
02/2018
1
Blood Proteins (Serum Proteins)
IBA
01/2017
1
Biocompatible Materials (Biomaterials)
IBA
01/2014
Therapy/Procedure
1
Therapeutics
01/2021